Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to the short-term effects of sigh breaths during High-frequency oscillatory ventilation (HFOV) in neonate undergoing mechanical ventilation. From meta-analysis, It revealed HFOV in neonates could reduce chronic lung disease or death rather than conventional ventilation. The main question it aims to answer is: Do sigh breaths augment restoring lung volume and ventilation (CO2 level) in intubated neonate with HFOV? Participants will be applied sigh breaths (HFOV-sigh) during on HFOV. Researchers will compare HFOV-sigh mode to see if CO2 level (before-after intervention).


Clinical Trial Description

Sample size calculation (before and after intervention: two dependent mean) - alpha = 0.05, beta = 0.2, - Delta = 1.9, SD. = 4.35 - Calculated sample size = 42 - increase sample size if loss follow up 20% - Final sample size (n) = 50 Subgroup analysis for - preterm neonates - very preterm or very low birth weight neonates - extremely preterm or extremely low birth weight neonates ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05682937
Study type Interventional
Source Prince of Songkla University
Contact
Status Enrolling by invitation
Phase N/A
Start date January 12, 2023
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT02973373 - MRI of the Chest Under High Frequency Ventilation N/A
Recruiting NCT02712190 - Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation. N/A
Completed NCT04323397 - Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study N/A